FindTrial
Sign In

A Clinical Trial Depicting Factors Associated with NAFLD and their effect on Severity of NAFLD

Clinical Study Of Factors Affecting Severity Of NAFLD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052714
Enrollment
100
Registered
2023-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Ansh Chaudhary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age more than 18 Years 2)All patients diagnosed as fatty liver by abdominal ultrasonography

Exclusion criteria

Exclusion criteria: 1)chronic liver diseases, including hepatitis B or C 2)alcoholic liver disease. 3)Patients on hepatotoxic medications. 4)Advanced liver disease 5)Cardiac failure 6)Acute fatty liver of pregnancy 7)Patients known case of Autoimmune Hepatitis 8)Any known Malignancy 9)Patients not giving consent

Design outcomes

Primary

MeasureTime frame
1) Occurrence Of Vit B12 Deficiency In NAFLD 2) Occurrence of Thyroid Abnormalities in NAFLD 3) Diagnostic Accuracies of Predictive scoring systems in NAFLD Timepoint: 1.5 years—

Secondary

MeasureTime frame
1) Occurrence Of Vit B12 Deficiency In NAFLD 2) Occurrence of Thyroid Abnormalities in NAFLD 3) Diagnostic Accuracies of Predictive scoring systems in NAFLD Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Cynthia Amrutha

Kasturba Hospital And Medical College Manipal

ansh2697@gmail.com8171370149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026